New hope for ovarian cancer: drug may delay return of disease

NCT ID NCT04884360

Ongoing Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether the drug olaparib can help keep advanced ovarian cancer from coming back in people who do not have a BRCA gene mutation. Participants have already responded well to initial chemotherapy. The trial compares olaparib to a placebo to see if it extends the time before the cancer progresses. About 366 people are taking part in this Phase 3 study.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fallopian tube cancer ovarian cancer ovarian endometrioid adenocarcinoma ovarian serous adenocarcinoma primary peritoneal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVARIAN CANCER

Contacts and locations

Locations

Research Site

Santiago, 8241479, Chile
Research Site

Santiago, 8420383, Chile
Research Site

Temuco, 4800827, Chile
Research Site

Temuco, 4810218, Chile
Research Site

Viña del Mar, 2540488, Chile
Research Site

Baoji, 721008, China
Research Site

Beijing, 100034, China
Research Site

Beijing, 100142, China
Research Site

Changchun, 130021, China
Research Site

Changsha, 410013, China
Research Site

Chengdu, 610041, China
Research Site

Chengdu, 610072, China
Research Site

Chongqing, 400038, China
Research Site

Chongqing, 400042, China
Research Site

Guangzhou, 510095, China
Research Site

Guangzhou, 510120, China
Research Site

Guiyang, 550004, China
Research Site

Haikou, 570311, China
Research Site

Hangzhou, 310022, China
Research Site

Hefei, 230001, China
Research Site

Hefei, 230601, China
Research Site

Jiaxing, 314001, China
Research Site

Jining, 272029, China
Research Site

Lanzhou, 730030, China
Research Site

Linyi, 276000, China
Research Site

Nanjing, 210009, China
Research Site

Qingdao, 266034, China
Research Site

Rui’an, 325200, China
Research Site

Shanghai, 200011, China
Research Site

Shanghai, 200032, China
Research Site

Shenyang, 110042, China
Research Site

Suzhou, 215004, China
Research Site

Tianjin, 300050, China
Research Site

Tianjin, 300060, China
Research Site

Ürümqi, 830000, China
Research Site

Ürümqi, 830054, China
Research Site

Wenzhou, 325027, China
Research Site

Wenzhou, CN-325000, China
Research Site

Wuhan, 430000, China
Research Site

Wuhan, 430022, China
Research Site

Wuxi, 214062, China
Research Site

Xuzhou, 221000, China
Research Site

Xuzhou, 221009, China
Research Site

Yanji, 133000, China
Research Site

Zibo, 255200, China
Research Site

Zunyi, 563100, China
Research Site

Bogotá, 110221, Colombia
Research Site

Bogotá, Colombia
Research Site

Medellín, 50030, Colombia
Research Site

Gurgaon, 122001, India
Research Site

Jaipur, 302017, India
Research Site

Kolkata, 700160, India
Research Site

Madurai, 625107, India
Research Site

Namakkal, 637001, India
Research Site

Nashik, 422002, India
Research Site

New Delhi, 110085, India
Research Site

New Delhi, 11029, India
Research Site

Arequipa, AREQUIPA01, Peru
Research Site

Lima, 15036, Peru
Research Site

Lima, LIMA 29, Peru
Research Site

Lima, LIMA 34, Peru
Research Site

San Isidro, 27, Peru
Research Site

Arkhangelsk, 163045, Russia
Research Site

Chelyabinsk, 454087, Russia
Research Site

Moscow, 115478, Russia
Research Site

Moscow, 117997, Russia
Research Site

Saint Petersburg, 197758, Russia
Research Site

Saint Petersburg, 198255, Russia
Research Site

Tomsk, 634028, Russia
Research Site

Yekaterinburg, 620905, Russia
Research Site

Port Elizabeth, 6045, South Africa
Research Site

Adana, 01120, Turkey (Türkiye)
Research Site

Ankara, 06100, Turkey (Türkiye)
Research Site

Ankara, 06800, Turkey (Türkiye)
Research Site

Cordaleo, 35575, Turkey (Türkiye)
Research Site

Istanbul, 34010, Turkey (Türkiye)
Research Site

Samsun, 55139, Turkey (Türkiye)
Research Site

Chernihiv, 14029, Ukraine
Research Site

Dnipro, 49102, Ukraine
Research Site

Ivano-Frankivsk, 76018, Ukraine
Research Site

Kharkiv, 61103, Ukraine
Research Site

Kryvyi Rih, 50048, Ukraine
Research Site

Kyiv, 03022, Ukraine
Research Site

Kyiv, 04050, Ukraine
Research Site

Zaporizhzhia, Ukraine
Research Site

Hanoi, 100000, Vietnam
Research Site

Hà Nội, 100000, Vietnam
Research Site

Ho Chi Minh City, 700000, Vietnam
Research Site

Ho Chi Minh City, Vietnam

More trials for these conditions

Other studies related to the condition(s) this trial covers.